ASH 2018 | Is CLL chemoimmunotherapy finished?
Please rate this video
Thanks for your feedback, this will help us improve our content for you!
Robin Foà, MD, of Sapienza University of Rome, Rome, Italy, gives us his take on the key chronic lymphocytic leukemia (CLL) highlights from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. Prof. Foà highlights novel agents changing the treatment landscape.
Get great new content delivered to your inboxSign up